TIDES development and manufacturing

At WuXi TIDES, we provide a perfectly orchestrated CRDMO platform offering comprehensive development and manufacturing services for peptide and oligonucleotide therapeutics. From custom peptide synthesis to morpholino oligonucleotide (PMO) production, we help ensure precision from discovery to commercialization.

For API development and manufacturing, our industry-leading capabilities across multiple sites are extensive. We support both oligonucleotides (handling millimoles to moles across 30+ manufacturing lines) and peptides (from grams to metric tons, utilizing over 41,000 L total SPPS reactor volume). Our robust platforms include advanced process R&D and scalable production for diverse modalities, including complex conjugates.

Beyond APIs, our services extend to drug product development and manufacturing, where we offer formulation expertise for various oral and injectable dosage forms. This includes advanced formulations like LNPs, with a total parenteral capacity of 70 million units annually. Integrated analytical capabilities provide comprehensive method development, validation, and testing for both drug substance and product. Finally, our dedicated clinical trial supply services ensure efficient packaging, labeling, and global distribution to accelerate your programs. No detail overlooked.